4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-20-022450
CHIEF FINANCIAL OFFICER bought 60,000 shares at an average $0.19 ($11,558)
From the SEC's structured data for this filing
Trades in this filing
Shah Amit B. · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-20 | Purchase : show line 1 in the form | +31,692 | $0.20 | $6,180 | 31,692 | D |
| 2020-11-23 | Purchase : show line 2 in the form | +20,088 | $0.19 | $3,817 | 51,780 | D |
| 2020-11-24 | Purchase : show line 3 in the form | +8,220 | $0.19 | $1,562 | 60,000 | D |
| Open-market purchases · 60,000 sh · avg $0.19 · $11,558 | ||||||
Loading xslF345X03/ownership.xml…